Condition: Tricuspid Regurgitation (TR) · Sponsor: Abbott Medical Devices
The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
This description comes directly from the study's public registry record.
Allison Wood · 612-518-9034 · allison.wood@abbott.com
Jennifer Studt · 314-616-2790 · jennifer.studt@abbott.com
Always discuss trial participation with your own doctor first.
| Scripps Health | La Jolla, California, United States | Not Yet Recruiting |
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Not Yet Recruiting |
| Ospedale San Raffaele - Cardiac | Milan, Lombard, Italy | Not Yet Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07586995